Combined treatment of patients with bone metastases from various cancers with nivolumab plus denosumab: A retrospective study.

e14153Background: Monoclonal antibodies against the programmed cell death protein-1 (PD-1), e.g., nivolumab, have been shown to exhibit antitumor immunity and improve survival in patients with vari...